| | | |  | | | | By Adam Feuerstein Kirsty Wigglesworth/AP The decision on the drug, which secured accelerated in 2020, follows a request from the Food and Drug Administration Read More | | By Adam Feuerstein Molly Ferguson/STAT Data involving the treatment called DCVax might appear to be encouraging, but they're based on a post-hoc analysis. Read More | | By Allison DeAngelis Adobe Cancer patients often worry whether the disease will return. A new test that searches blood for traces of cancer DNA could offer answers. Read More | | Sponsored Insight by Amgen Oncology Lung cancer & biomarker testing: Why test? When to test? And how to test? Find out here. The rapid development of new targeted cancer therapies has improved the treatment landscape for patients with lung cancer. But without biomarker testing, these patients could miss out on important treatment options. Barriers to biomarker testing still exist but can be overcome to expand access to precision medicine for more patients. Read on to learn more. | | By Jonathan Wosen Lorna McInroy/Wellcome The unprecedented success of mRNA Covid vaccines is raising hopes that the technology could lead to new and better vaccines against cancer. Read More | | By Sarah Owermohle STAT "Science and technology policy is one of the few places where one can get any kind of bipartisan cooperation." Read More | |
No comments